International Psoriasis Council
Advancing Knowledge. Improving Care.
The IPC Psoriasis Masterclass is designed for early-career dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis. Focusing on fostering a small group environment, this FREE program offers an intimate and personalized learning experience, ensuring each participant receives the utmost attention and support.
This Masterclass is led by an esteemed faculty of international experts boasting extensive experience in psoriasis care. Our aim is to equip attendees with cutting-edge skills and knowledge to elevate their careers and become leaders in the field of psoriasis. Through lectures, panels, case-based discussions, and question-answer sessions, attendees will obtain practical and essential information for their clinical practice.
The IPC Masterclass is open to dermatologists who meet the following criteria:
Generously sponsored by our corporate partners, IPC will cover the cost of your 1-night stay at the Traders Hotel, Kuala Lumpur, and will provide lunch during the program and an evening reception at its conclusion.
Schedule:
Wednesday, October 2
07:30 – Registration
08:30 – Program Begins
18:00 – Program Ends & Reception
The Masterclass is open to only 60 exceptional participants, carefully selected from those eager to elevate their expertise in managing and treating psoriasis. If you are a Dermatologist from Asia with a strong foundation in dermatology, this program is tailor-made for you.
We are no longer accepting applications for this program.
REGISTRATION – 07:30
WELCOME + INTRODUCTION
Siew Eng Choon, Malaysia
Epidemiology and the Disease Burden of Psoriasis in Asia
Azura Mohd Affandi, Malaysia
Unveiling the Pathogenesis of Psoriasis: A Bridge to Personalized Care
Jonathan Barker, United Kingdom
The Importance of Recognizing the Different Phenotypes of Psoriasis
Yukari Okubo, Japan
Psoriasis as a Systemic Disease
Azura Mohd Affandi, Malaysia
Psoriatic Arthritis for Dermatologists
Bryan Guevara, Philippines
BREAK
How to Assess Disease Severity and Treatment Outcomes in Clinical Practice
Pravit Asawanonda, Thailand
Optimizing the Use of Topical Therapy and Conventional Systemic Agents
Julia Huang, Taiwan
Phototherapy: Current Use and Developments
Akimichi Morita, Japan
Optimizing the Use of Biologics and Biosimilars
Hazel Oon, Singapore
Panel Q&A
All Faculty
LUNCH
FACULTY FORUM: CHALLENGING CASES
Generalized Pustular Psoriasis
Seong-jin Jo, Republic of Korea
Palmoplantar Psoriasis
Rudi Chandra, Indonesia
Erythrodermic Psoriasis
Bryan Guevara, Philippines
Psoriasis and TB
Pravit Asawanonda, Thailand
Psoriasis and Hepatitis
Julia Huang, Taiwan
Malignancy and Psoriasis
Francis Lai, Australia
Pregnancy & Breastfeeding
Hazel Oon, Singapore
Pediatric Psoriasis
Siew Eng Choon, Malaysia
TEA BREAK
New and Emerging Treatments for Psoriasis
Seong-jin Jo, Republic of Korea
Challenging Cases Workshop – Presented by Delegates
Faculty Panel
Integrating the Lessons from the Masterclass
All Faculty
Closing Comments
Siew Eng Choon, Malaysia
RECEPTION/DINNER
Lodging and Meeting Location:
Traders Hotel Kuala Lumpur
Kuala Lumpur City Centre
50088 Malaysia
Check-in: 15:00 | Check-out: 12:00
IPC will pay for a 1-night stay at Traders Hotel Kuala Lumpur in Malaysia for each participant.
Meeting Location:
Kuala Lumpur Convention Centre (KLCC), Room 302-303, Level 3
Kuala Lumpur
50088 Kuala Lumpur
Wilayah Persekutuan Kuala Lumpur, Malaysia
Transportation
Participants are responsible for arranging and financing their air and ground transportation to the event. We recommend booking your flights well in advance to secure the best rates and ensure that your travel plans allow attendance for the entire program.
Traders Hotel Kuala Lumpur and the KLCC are approximately 45 minutes from Kuala Lumpur International Airport Terminal 1 (KLIA) and approximately 55 minutes from Kuala Lumpur International Airport Terminal 2 (KLIA2).
Ground
There are several options to reach Traders Hotel Kuala Lumpur:
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
